CureVac B.V.(CVAC)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CVAC CureVac B.V.

交易中 07-03 12:14:31 EDT

3.26

-0.08

-2.54%

最高3.80	最低3.23	成交量615.34万
今开3.80	昨收3.34	日振幅17.07%
总市值7.30亿	流通市值3.99亿	总股本2.24亿
成交额2,129万	换手率5.02%	流通股本1.22亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"CVAC","market":"US","secType":"STK","nameCN":"CureVac B.V.","latestPrice":3.255,"timestamp":1720023246468,"preClose":3.34,"halted":0,"volume":6153383,"delay":0,"floatShares":122492226,"shares":224291745,"eps":-1.316051,"marketStatus":"交易中","marketStatusCode":2,"change":-0.085,"latestTime":"07-03 12:14:31 EDT","open":3.797,"high":3.8,"low":3.23,"amount":21292261.985898998,"amplitude":0.170659,"askPrice":3.26,"askSize":600,"bidPrice":3.25,"bidSize":4700,"shortable":3,"etf":0,"ttmEps":-1.316051,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1720026000000},"adr":0,"listingDate":1597377600000,"adjPreClose":3.34,"preHourTrading":{"tag":"盘前","latestPrice":3.79,"preClose":3.34,"latestTime":"09:29 EDT","volume":760750,"amount":3004676.1536999997,"timestamp":1720013399999},"postHourTrading":{"tag":"盘后","latestPrice":3.45,"preClose":3.34,"latestTime":"19:57 EDT","volume":223,"amount":766.12,"timestamp":1719964678966},"volumeRatio":20.969988,"impliedVol":1.2493,"impliedVolPercentile":0.6587},"requestUrl":"/m/hq/s/CVAC","defaultTab":"news","newsList":[{"id":"2448488080","title":"Curevac N.V.股价上涨11.23% 市值涨9357.91万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2448488080","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448488080?lang=zh_cn&edition=full","pubTime":"2024-07-03 21:31","pubTimestamp":1720013467,"startTime":"0","endTime":"0","summary":"北京时间2024年07月03日21时31分，Curevac N.V.股票出现波动，股价大幅拉升11.23%。Curevac N.V.股票所在的生物技术行业中，整体跌幅为0.24%。Curevac N.V.公司简介：CureVac NV是一家总部位于德国的生物制药公司，利用信使核糖核酸开发疫苗和治疗方法。CureVac正在与GSK合作开发第二代新冠疫苗。CureVac最初尝试开发新冠疫苗并未获得足够的有效性数据，其试验在2021年10月停止。此外，CureVac正处于早期阶段，开发用于肿瘤、肝脏、眼睛和肺部疾病的肿瘤学和分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240703213107956e186b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240703213107956e186b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4551","BK4548","CVAC"],"gpt_icon":0},{"id":"2448817360","title":"CureVac盘前大涨，向葛兰素史克卖出流感和新冠疫苗版权","url":"https://stock-news.laohu8.com/highlight/detail?id=2448817360","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448817360?lang=zh_cn&edition=full","pubTime":"2024-07-03 16:37","pubTimestamp":1719995825,"startTime":"0","endTime":"0","summary":"在这一消息提振之下，CureVac股价在美股夜盘交易时段跳涨超23%。据了解，葛兰素史克与生物科技公司CureVac的这一合作关系始于2020年全球新冠疫情期间，两家公司合作开发基于mRNA技术的传染病疫苗。葛兰素史克是世界领先的疫苗制造商之一。据了解，CureVac正在出售其主要的疫苗开发项目，接受葛兰素史克的预付款，以提高其现金流基本状况，并专注于新的癌症治疗方法。","market":"us","thumbnail":"https://static.tigerbbs.com/6ad7ed6b96b448ffcc5b5501b0dc346c","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/6ad7ed6b96b448ffcc5b5501b0dc346c"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1144975.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["CVAC","BK4548","BK4532","BK4139","BK4551","BK4585","LU1829250122.USD","BK4007","BK4588"],"gpt_icon":1},{"id":"2446165003","title":"Curevac N.V.盘中异动 股价大跌5.08%报3.36美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2446165003","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446165003?lang=zh_cn&edition=full","pubTime":"2024-06-27 00:26","pubTimestamp":1719419189,"startTime":"0","endTime":"0","summary":"北京时间2024年06月27日00时26分，Curevac N.V.股票出现波动，股价急速下挫5.08%。Curevac N.V.股票所在的生物技术行业中，整体跌幅为0.97%。Curevac N.V.公司简介：CureVac NV是一家总部位于德国的生物制药公司，利用信使核糖核酸开发疫苗和治疗方法。CureVac正在与GSK合作开发第二代新冠疫苗。CureVac最初尝试开发新冠疫苗并未获得足够的有效性数据，其试验在2021年10月停止。此外，CureVac正处于早期阶段，开发用于肿瘤、肝脏、眼睛和肺部疾病的肿瘤学和分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240627002630aef6c231&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240627002630aef6c231&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CVAC","BK4548","BK4139","BK4551"],"gpt_icon":0},{"id":"2446272158","title":"Curevac N.V.盘中异动 股价大涨5.04%报3.65美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2446272158","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446272158?lang=zh_cn&edition=full","pubTime":"2024-06-26 02:17","pubTimestamp":1719339453,"startTime":"0","endTime":"0","summary":"北京时间2024年06月26日02时17分，Curevac N.V.股票出现异动，股价急速上涨5.04%。Curevac N.V.股票所在的生物技术行业中，整体涨幅为1.35%。Curevac N.V.公司简介：CureVac NV是一家总部位于德国的生物制药公司，利用信使核糖核酸开发疫苗和治疗方法。CureVac正在与GSK合作开发第二代新冠疫苗。CureVac最初尝试开发新冠疫苗并未获得足够的有效性数据，其试验在2021年10月停止。此外，CureVac正处于早期阶段，开发用于肿瘤、肝脏、眼睛和肺部疾病的肿瘤学和分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240626021733af8f2438&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240626021733af8f2438&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CVAC","BK4551","BK4548","BK4139"],"gpt_icon":0},{"id":"2445205003","title":"Curevac N.V.盘中异动 股价大涨5.21%报3.43美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2445205003","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445205003?lang=zh_cn&edition=full","pubTime":"2024-06-24 23:02","pubTimestamp":1719241326,"startTime":"0","endTime":"0","summary":"北京时间2024年06月24日23时02分，Curevac N.V.股票出现异动，股价大幅上涨5.21%。Curevac N.V.股票所在的生物技术行业中，整体涨幅为1.37%。Curevac N.V.公司简介：CureVac NV是一家总部位于德国的生物制药公司，利用信使核糖核酸开发疫苗和治疗方法。CureVac正在与GSK合作开发第二代新冠疫苗。CureVac最初尝试开发新冠疫苗并未获得足够的有效性数据，其试验在2021年10月停止。此外，CureVac正处于早期阶段，开发用于肿瘤、肝脏、眼睛和肺部疾病的肿瘤学和分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240624230206941f0993&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240624230206941f0993&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4551","BK4548","BK4139","CVAC"],"gpt_icon":0},{"id":"2444116385","title":"Curevac N.V.盘中异动 股价大跌5.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2444116385","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444116385?lang=zh_cn&edition=full","pubTime":"2024-06-18 03:05","pubTimestamp":1718651126,"startTime":"0","endTime":"0","summary":"北京时间2024年06月18日03时05分，Curevac N.V.股票出现异动，股价快速跳水5.45%。Curevac N.V.股票所在的生物技术行业中，整体跌幅为0.19%。Curevac N.V.公司简介：CureVac NV是一家总部位于德国的生物制药公司，利用信使核糖核酸开发疫苗和治疗方法。CureVac正在与GSK合作开发第二代新冠疫苗。CureVac最初尝试开发新冠疫苗并未获得足够的有效性数据，其试验在2021年10月停止。此外，CureVac正处于早期阶段，开发用于肿瘤、肝脏、眼睛和肺部疾病的肿瘤学和分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240618030526aef54d02&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240618030526aef54d02&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CVAC","BK4548","BK4139","BK4551"],"gpt_icon":0},{"id":"2443620031","title":"Curevac N.V.盘中异动 早盘股价大跌5.80%报3.77美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2443620031","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2443620031?lang=zh_cn&edition=full","pubTime":"2024-06-14 21:30","pubTimestamp":1718371849,"startTime":"0","endTime":"0","summary":"北京时间2024年06月14日21时30分，Curevac N.V.股票出现波动，股价急速下挫5.80%。截至发稿，该股报3.77美元/股，成交量2.8973万股，换手率0.01%，振幅0.25%。Curevac N.V.股票所在的生物技术行业中，整体涨幅为0.32%。Curevac N.V.公司简介：CureVac NV是一家总部位于德国的生物制药公司，利用信使核糖核酸开发疫苗和治疗方法。CureVac正在与GSK合作开发第二代新冠疫苗。此外，CureVac正处于早期阶段，开发用于肿瘤、肝脏、眼睛和肺部疾病的肿瘤学和分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240614213049af8da1be&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240614213049af8da1be&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LGVN","BK4551","CVAC","BK4548"],"gpt_icon":0},{"id":"2443963169","title":"Curevac N.V.盘中异动 股价大跌5.06%报3.94美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2443963169","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2443963169?lang=zh_cn&edition=full","pubTime":"2024-06-14 01:37","pubTimestamp":1718300225,"startTime":"0","endTime":"0","summary":"北京时间2024年06月14日01时37分，Curevac N.V.股票出现异动，股价快速跳水5.06%。Curevac N.V.股票所在的生物技术行业中，整体跌幅为0.19%。Curevac N.V.公司简介：CureVac NV是一家总部位于德国的生物制药公司，利用信使核糖核酸开发疫苗和治疗方法。CureVac正在与GSK合作开发第二代新冠疫苗。CureVac最初尝试开发新冠疫苗并未获得足够的有效性数据，其试验在2021年10月停止。此外，CureVac正处于早期阶段，开发用于肿瘤、肝脏、眼睛和肺部疾病的肿瘤学和分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240614013705af8d71da&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240614013705af8d71da&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CVAC","BK4548","BK4139","LGVN","BK4551"],"gpt_icon":0},{"id":"2442355446","title":"Curevac N.V.盘中异动 早盘股价大涨5.41%报4.48美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2442355446","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2442355446?lang=zh_cn&edition=full","pubTime":"2024-06-12 21:32","pubTimestamp":1718199127,"startTime":"0","endTime":"0","summary":"北京时间2024年06月12日21时32分，Curevac N.V.股票出现异动，股价大幅拉升5.41%。Curevac N.V.股票所在的生物技术行业中，整体涨幅为0.39%。Curevac N.V.公司简介：CureVac NV是一家总部位于德国的生物制药公司，利用信使核糖核酸开发疫苗和治疗方法。CureVac正在与GSK合作开发第二代新冠疫苗。CureVac最初尝试开发新冠疫苗并未获得足够的有效性数据，其试验在2021年10月停止。此外，CureVac正处于早期阶段，开发用于肿瘤、肝脏、眼睛和肺部疾病的肿瘤学和分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061221320896813b1e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061221320896813b1e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4551","CVAC","BK4548"],"gpt_icon":0},{"id":"2442917413","title":"Curevac N.V.盘中异动 早盘大幅下挫5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2442917413","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2442917413?lang=zh_cn&edition=full","pubTime":"2024-06-11 21:33","pubTimestamp":1718112831,"startTime":"0","endTime":"0","summary":"北京时间2024年06月11日21时33分，Curevac N.V.股票出现异动，股价快速下跌5.01%。Curevac N.V.股票所在的生物技术行业中，整体跌幅为0.37%。Curevac N.V.公司简介：CureVac NV是一家总部位于德国的生物制药公司，利用信使核糖核酸开发疫苗和治疗方法。CureVac正在与GSK合作开发第二代新冠疫苗。CureVac最初尝试开发新冠疫苗并未获得足够的有效性数据，其试验在2021年10月停止。此外，CureVac正处于早期阶段，开发用于肿瘤、肝脏、眼睛和肺部疾病的肿瘤学和分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240611213351af8cf458&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240611213351af8cf458&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CVAC","BK4551","BK4548","BK4139"],"gpt_icon":0},{"id":"2441113271","title":"Curevac N.V.盘中异动 急速上涨5.20%报4.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2441113271","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441113271?lang=zh_cn&edition=full","pubTime":"2024-06-05 21:40","pubTimestamp":1717594808,"startTime":"0","endTime":"0","summary":"北京时间2024年06月05日21时40分，Curevac N.V.股票出现波动，股价大幅拉升5.20%。Curevac N.V.股票所在的生物技术行业中，整体涨幅为0.29%。Curevac N.V.公司简介：CureVac NV是一家总部位于德国的生物制药公司，利用信使核糖核酸开发疫苗和治疗方法。CureVac正在与GSK合作开发第二代新冠疫苗。CureVac最初尝试开发新冠疫苗并未获得足够的有效性数据，其试验在2021年10月停止。此外，CureVac正处于早期阶段，开发用于肿瘤、肝脏、眼睛和肺部疾病的肿瘤学和分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240605214008941ec91e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240605214008941ec91e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4551","BK4139","CVAC","BK4548"],"gpt_icon":0},{"id":"2440235289","title":"Curevac N.V.盘中异动 早盘股价大涨5.07%报4.56美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2440235289","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2440235289?lang=zh_cn&edition=full","pubTime":"2024-06-04 21:34","pubTimestamp":1717508050,"startTime":"0","endTime":"0","summary":"北京时间2024年06月04日21时34分，Curevac N.V.股票出现波动，股价快速上涨5.07%。Curevac N.V.股票所在的生物技术行业中，整体跌幅为0.04%。Curevac N.V.公司简介：CureVac NV是一家总部位于德国的生物制药公司，利用信使核糖核酸开发疫苗和治疗方法。CureVac正在与GSK合作开发第二代新冠疫苗。CureVac最初尝试开发新冠疫苗并未获得足够的有效性数据，其试验在2021年10月停止。此外，CureVac正处于早期阶段，开发用于肿瘤、肝脏、眼睛和肺部疾病的肿瘤学和分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240604213411941ec400&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240604213411941ec400&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4548","ANNX","CVAC","BK4551"],"gpt_icon":0},{"id":"2440496905","title":"Curevac N.V.盘中异动 早盘股价大涨5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2440496905","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2440496905?lang=zh_cn&edition=full","pubTime":"2024-06-03 21:46","pubTimestamp":1717422366,"startTime":"0","endTime":"0","summary":"北京时间2024年06月03日21时46分，Curevac N.V.股票出现波动，股价大幅上涨5.01%。Curevac N.V.股票所在的生物技术行业中，整体涨幅为0.77%。Curevac N.V.公司简介：CureVac NV是一家总部位于德国的生物制药公司，利用信使核糖核酸开发疫苗和治疗方法。CureVac正在与GSK合作开发第二代新冠疫苗。CureVac最初尝试开发新冠疫苗并未获得足够的有效性数据，其试验在2021年10月停止。此外，CureVac正处于早期阶段，开发用于肿瘤、肝脏、眼睛和肺部疾病的肿瘤学和分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240603214606941ebe6a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240603214606941ebe6a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4551","CVAC","BK4548","BK4139"],"gpt_icon":0},{"id":"2439624992","title":"Curevac N.V.盘中异动 大幅拉升5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2439624992","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439624992?lang=zh_cn&edition=full","pubTime":"2024-05-31 21:38","pubTimestamp":1717162716,"startTime":"0","endTime":"0","summary":"北京时间2024年05月31日21时38分，Curevac N.V.股票出现波动，股价快速上涨5.04%。Curevac N.V.股票所在的生物技术行业中，整体涨幅为1.19%。Curevac N.V.公司简介：CureVac NV是一家总部位于德国的生物制药公司，利用信使核糖核酸开发疫苗和治疗方法。CureVac正在与GSK合作开发第二代新冠疫苗。CureVac最初尝试开发新冠疫苗并未获得足够的有效性数据，其试验在2021年10月停止。此外，CureVac正处于早期阶段，开发用于肿瘤、肝脏、眼睛和肺部疾病的肿瘤学和分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240531213836af8b66c8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240531213836af8b66c8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4548","BK4551","BK4139","CVAC"],"gpt_icon":0},{"id":"2439578229","title":"Curevac N.V.盘中异动 早盘快速下跌5.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2439578229","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439578229?lang=zh_cn&edition=full","pubTime":"2024-05-29 21:48","pubTimestamp":1716990488,"startTime":"0","endTime":"0","summary":"北京时间2024年05月29日21时48分，Curevac N.V.股票出现异动，股价快速跳水5.18%。Curevac N.V.股票所在的生物技术行业中，整体跌幅为0.74%。Curevac N.V.公司简介：CureVac NV是一家总部位于德国的生物制药公司，利用信使核糖核酸开发疫苗和治疗方法。CureVac正在与GSK合作开发第二代新冠疫苗。CureVac最初尝试开发新冠疫苗并未获得足够的有效性数据，其试验在2021年10月停止。此外，CureVac正处于早期阶段，开发用于肿瘤、肝脏、眼睛和肺部疾病的肿瘤学和分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240529214808aef2564f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240529214808aef2564f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CVAC","BK4139","BK4548","BK4551"],"gpt_icon":0},{"id":"2438305365","title":"Curevac N.V.盘中异动 股价大跌5.15%报3.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2438305365","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2438305365?lang=zh_cn&edition=full","pubTime":"2024-05-28 22:42","pubTimestamp":1716907355,"startTime":"0","endTime":"0","summary":"北京时间2024年05月28日22时42分，Curevac N.V.股票出现波动，股价快速下挫5.15%。Curevac N.V.股票所在的生物技术行业中，整体跌幅为1.72%。Curevac N.V.公司简介：CureVac NV是一家总部位于德国的生物制药公司，利用信使核糖核酸开发疫苗和治疗方法。CureVac正在与GSK合作开发第二代新冠疫苗。CureVac最初尝试开发新冠疫苗并未获得足够的有效性数据，其试验在2021年10月停止。此外，CureVac正处于早期阶段，开发用于肿瘤、肝脏、眼睛和肺部疾病的肿瘤学和分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240528224235af8ab555&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240528224235af8ab555&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4551","BK4139","BK4548","CVAC"],"gpt_icon":0},{"id":"2437058032","title":"Curevac N.V.盘中异动 股价大跌5.16%报3.77美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2437058032","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2437058032?lang=zh_cn&edition=full","pubTime":"2024-05-24 21:54","pubTimestamp":1716558862,"startTime":"0","endTime":"0","summary":"北京时间2024年05月24日21时54分，Curevac N.V.股票出现波动，股价大幅下跌5.16%。Curevac N.V.股票所在的生物技术行业中，整体涨幅为0.14%。Curevac N.V.公司简介：CureVac NV是一家总部位于德国的生物制药公司，利用信使核糖核酸开发疫苗和治疗方法。CureVac正在与GSK合作开发第二代新冠疫苗。此外，CureVac正处于早期阶段，开发用于肿瘤、肝脏、眼睛和肺部疾病的肿瘤学和分子疗法。消息层面，截至21时54分，《JMP Securities维持CureVac买入评级，维持目标价18美元》资讯为影响Curevac N.V.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240524215423941ea04f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240524215423941ea04f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4551","CVAC","BK4139","BK4548"],"gpt_icon":0},{"id":"2437742225","title":"隔夜美股全复盘(5.23)| 英伟达净利暴增628%，宣布进行1拆10，营收及指引均超预期，盘后股价突破1000","url":"https://stock-news.laohu8.com/highlight/detail?id=2437742225","media":"格隆汇","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2437742225?lang=zh_cn&edition=full","pubTime":"2024-05-23 07:39","pubTimestamp":1716421147,"startTime":"0","endTime":"0","summary":"英伟达净利暴增628%，宣布进行1拆10，营收及指引均超预期，盘后股价突破1000","market":"sg","thumbnail":"https://static.tigerbbs.com/f99f24db6c49bc285a0fe73ae0252f23","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/f99f24db6c49bc285a0fe73ae0252f23"],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/748839","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["DIS","BNTX","CMCSA","688223","DQ","CVAC","LLY","AZN","SSNLF","TGT","VIR","NVDA","JKS","SNOW","NVAX","AMZN","MRNA"],"gpt_icon":1},{"id":"1123275807","title":"禽流感蔓延引发恐慌！美股疫苗股全线大幅收高","url":"https://stock-news.laohu8.com/highlight/detail?id=1123275807","media":"老虎资讯综合","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/1123275807?lang=zh_cn&edition=full","pubTime":"2024-05-23 06:13","pubTimestamp":1716416028,"startTime":"0","endTime":"0","summary":"5月22日，美国确认了第二例人感染禽流感病例，受此影响，疫苗概念股全线走高。截至收盘，$BioNTech(BNTX)$涨11.1%，$CureVac(CVAC)$涨18.8%，$Moderna(MRNA)$涨13.7%，$Vir Biotechnology(VIR)$涨11.4%，$辉瑞(PFE)$涨3.7%。","market":"us","thumbnail":"https://static.tigerbbs.com/5ce7e4c84e3c54b81fbaee9cb1c77ad9","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/5ce7e4c84e3c54b81fbaee9cb1c77ad9"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BNTX","MRNA","PFE","CVAC","VIR","NVAX"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.curevac.com","stockEarnings":[{"period":"1week","weight":-0.0565},{"period":"1month","weight":-0.1414},{"period":"3month","weight":0.1478},{"period":"6month","weight":-0.2085},{"period":"1year","weight":-0.6899},{"period":"ytd","weight":-0.2067}],"compareEarnings":[{"period":"1week","weight":0.0077},{"period":"1month","weight":0.041},{"period":"3month","weight":0.057},{"period":"6month","weight":0.1749},{"period":"1year","weight":0.2371},{"period":"ytd","weight":0.1551}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Curevac N.V.于2020年4月7日根据荷兰法律注册成立。该公司是一家全球性的临床阶段生物制药公司，开发基于信使核糖核酸的新型转化药物，该药物具有改善人们生活的潜力。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.074507},{"month":2,"riseRate":0.25,"avgChangeRate":-0.078931},{"month":3,"riseRate":0.25,"avgChangeRate":-0.042891},{"month":4,"riseRate":0.5,"avgChangeRate":0.009789},{"month":5,"riseRate":0.75,"avgChangeRate":0.226595},{"month":6,"riseRate":0.25,"avgChangeRate":-0.165776},{"month":7,"riseRate":0,"avgChangeRate":-0.125371},{"month":8,"riseRate":0.333333,"avgChangeRate":0.018529},{"month":9,"riseRate":0,"avgChangeRate":-0.189876},{"month":10,"riseRate":0.25,"avgChangeRate":-0.129659},{"month":11,"riseRate":0.75,"avgChangeRate":0.343537},{"month":12,"riseRate":0,"avgChangeRate":-0.226567}],"exchange":"NASDAQ","name":"CureVac B.V.","nameEN":"CureVac B.V."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.24.2","shortVersion":"4.24.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"CureVac B.V.(CVAC)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供CureVac B.V.(CVAC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"CureVac B.V.,CVAC,CureVac B.V.股票,CureVac B.V.股票老虎,CureVac B.V.股票老虎国际,CureVac B.V.行情,CureVac B.V.股票行情,CureVac B.V.股价,CureVac B.V.股市,CureVac B.V.股票价格,CureVac B.V.股票交易,CureVac B.V.股票购买,CureVac B.V.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"CureVac B.V.(CVAC)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供CureVac B.V.(CVAC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}